Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Pacific Biosciences Rises as SoftBank Invests $900 Million
By Rob Lenihan
Feb 10, 2021 1:41 PM EST
PRESS RELEASES
Invitae To Present At The 10th Annual SVB Leerink Global Healthcare Conference
By PR Newswire
Feb 10, 2021 7:30 AM EST
PRESS RELEASES
Invitae Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock And Closing Of Underwritten Public Offering
By PR Newswire
Jan 26, 2021 4:05 PM EST
PRESS RELEASES
Invitae Announces Pricing Of Public Offering Of Common Stock
By PR Newswire
Jan 21, 2021 8:37 PM EST
PRESS RELEASES
Invitae Announces Proposed Public Offering Of Common Stock
By PR Newswire
Jan 20, 2021 4:05 PM EST
PRESS RELEASES
Leading Biopharmaceutical Companies Select Invitae To Develop Standardized Panel To Detect Molecular Residual Disease (MRD) In Patients With Acute Myeloid Leukemia (AML)
By PR Newswire
Jan 14, 2021 7:30 AM EST
PRESS RELEASES
Pacific Biosciences And Invitae To Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform
By GlobeNewswire
Jan 13, 2021 8:02 AM EST
PRESS RELEASES
Invitae To Present At The 39th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Dec 29, 2020 7:30 AM EST
HEALTH
Best Biotech Stocks to Buy in 2021
By Bret Jensen
Jan 31, 2021 10:15 AM EST
PRESS RELEASES
Invitae Introduces Routine Exome Reanalysis To Help Patients Receive Diagnoses Faster
By PR Newswire
Dec 17, 2020 7:30 AM EST
PRESS RELEASES
Invitae To Present New Data Supporting Genetic Testing For All Breast Cancer Patients At The 2020 San Antonio Breast Cancer Symposium
By PR Newswire
Dec 9, 2020 7:30 AM EST
PRESS RELEASES
New Study Highlights The Importance Of Genetic Testing For Pancreatic Cancer Patients
By PR Newswire
Nov 19, 2020 10:57 AM EST
PRESS RELEASES
Passage Bio And Invitae Announce Collaboration To Facilitate Genetic Testing To Support Early Diagnosis And Greater Awareness Of Clinical Trials For Patients With GM1
By GlobeNewswire
Nov 9, 2020 7:00 AM EST
PRESS RELEASES
Research Highlights Frequency Of Genetic Risk Factors Among Men With Prostate Cancer, Suggests Role For Broader Screening
By PR Newswire
Oct 28, 2020 7:30 AM EDT
PRESS RELEASES
Invitae To Announce Third Quarter 2020 Financial Results On Thursday, November 5, 2020
By PR Newswire
Oct 23, 2020 7:30 AM EDT
PRESS RELEASES
Invitae And Pacific Biosciences Collaborate To Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics
By GlobeNewswire
Oct 22, 2020 8:00 AM EDT
PRESS RELEASES
Taysha Gene Therapies Partners With Invitae To Enable Rapid Access To Genetic Testing And Earlier Diagnosis Of Patients With CNS Disease For Rare And Large-Market Indications
By Business Wire
Oct 6, 2020 7:00 AM EDT
PRESS RELEASES
Invitae Appoints Kimber Lockhart To Its Board Of Directors
By PR Newswire
Sep 11, 2020 7:30 AM EDT
PRESS RELEASES
PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program For Individuals Suspected Of Having Neurotransmitter Disorders
By PR Newswire
Sep 9, 2020 8:00 AM EDT
PRESS RELEASES
Multi-site Study To Evaluate The Role Of Testing Guidelines In Ensuring Access To Genetic Information For Men With Prostate Cancer
By PR Newswire
Sep 3, 2020 7:30 AM EDT
PRESS RELEASES
Invitae To Participate In The Morgan Stanley Virtual Global Healthcare Conference
By PR Newswire
Sep 1, 2020 7:30 AM EDT
PRESS RELEASES
Invitae Reports Inducement Grants Under NYSE Rule 303A.08
By PR Newswire
Aug 4, 2020 6:37 PM EDT
PRESS RELEASES
Invitae To Announce Second Quarter 2020 Financial Results On August 4, 2020
By PR Newswire
Jul 21, 2020 7:05 AM EDT
PRESS RELEASES
Moore Kuehn Encourages DCOM, MYOS, ADSW, And NVTA Investors To Contact Law Firm
By PR Newswire
Jul 8, 2020 1:19 PM EDT
PRESS RELEASES
INVITAE INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Merger Of Invitae Corporation - NVTA
By Business Wire
Jul 1, 2020 6:48 PM EDT
